{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:34:03Z","timestamp":1793414043025,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Funds of China","doi-asserted-by":"crossref","award":["82172775"],"award-info":[{"award-number":["82172775"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Clinical Specialty Construction Project 2021 Oncology","award":["2021GJLC01"],"award-info":[{"award-number":["2021GJLC01"]}]},{"name":"Anhui Province Cancer Bioimmunotherapy Clinical Medical Research Center","award":["202101B10202005"],"award-info":[{"award-number":["202101B10202005"]}]},{"name":"Breast cancer precision tumor research and innovation team","award":["2022AH010077"],"award-info":[{"award-number":["2022AH010077"]}]},{"name":"Beijing Science and Technology Innovation Medical Development Foundation Project","award":["KC2021-JF-0167-23"],"award-info":[{"award-number":["KC2021-JF-0167-23"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02546-8","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T14:54:35Z","timestamp":1749567275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["TCF19 expression and significance analysis in breast cancer: integrated bioinformatics analysis and histological validation"],"prefix":"10.1007","volume":"16","author":[{"given":"Haiyang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"issue":"3","key":"2546_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3322\/caac.21838","volume":"74","author":"N Jokhadze","year":"2024","unstructured":"Jokhadze N, Das A, Dizon DS. Global cancer statistics: a healthy population relies on population health. CA A Cancer J Clin. 2024;74(3):224\u20136. https:\/\/doi.org\/10.3322\/caac.21838.","journal-title":"CA A Cancer J Clin"},{"issue":"10385","key":"2546_CR2","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/S0140-6736(23)00505-6","volume":"401","author":"A Mahajan","year":"2023","unstructured":"Mahajan A. Improving access to global cancer services. Lancet. 2023;401(10385):1338\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(23)00505-6.","journal-title":"Lancet"},{"issue":"3","key":"2546_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2546_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.4103\/ijc.IJC_83_21","volume":"59","author":"MDA Bashar","year":"2022","unstructured":"Bashar MDA, Begam N. Breast cancer surpasses lung cancer as the most commonly diagnosed cancer worldwide. Indian J Cancer. 2022;59(3):438\u20139. https:\/\/doi.org\/10.4103\/ijc.IJC_83_21.","journal-title":"Indian J Cancer"},{"key":"2546_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-20301-6_1","volume":"1152","author":"A Ahmad","year":"2019","unstructured":"Ahmad A. Breast cancer statistics: recent trends. Adv Exp Med Biol. 2019;1152:1\u20137. https:\/\/doi.org\/10.1007\/978-3-030-20301-6_1.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"2546_CR6","doi-asserted-by":"publisher","first-page":"900","DOI":"10.20892\/j.issn.2095-3941.2020.0523","volume":"18","author":"S Lei","year":"2021","unstructured":"Lei S, Zheng R, Zhang S, et al. Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030. Cancer Biol Med. 2021;18(3):900\u20139. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0523.","journal-title":"Cancer Biol Med"},{"key":"2546_CR7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21863","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto AN, Sung H, Newman LA, et al. Breast cancer statistics. CA A Cancer J Clin. 2024. https:\/\/doi.org\/10.3322\/caac.21863. (Published online October 2024).","journal-title":"CA A Cancer J Clin"},{"key":"2546_CR8","doi-asserted-by":"publisher","first-page":"1093163","DOI":"10.3389\/fgene.2023.1093163","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Bi X, Luo Z, Wang H, Ismtula D, Guo C. Gelsolin: a comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers. Front Genet. 2023;14:1093163. https:\/\/doi.org\/10.3389\/fgene.2023.1093163.","journal-title":"Front Genet"},{"issue":"1","key":"2546_CR9","doi-asserted-by":"publisher","first-page":"8201","DOI":"10.1038\/s41598-024-58982-z","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li Y, Jing Y, et al. Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer. Sci Rep. 2024;14(1):8201. https:\/\/doi.org\/10.1038\/s41598-024-58982-z.","journal-title":"Sci Rep"},{"issue":"2","key":"2546_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.30699\/ijp.2023.562935.2983","volume":"18","author":"P Rustamadji","year":"2023","unstructured":"Rustamadji P, Wiyarta E, Anggreani I. Correlation of before and after invasive breast cancer neoadjuvant chemotherapy for NFkB, Cyclin D1, and survivin expression. Iran J Pathol. 2023;18(2):156\u201364. https:\/\/doi.org\/10.30699\/ijp.2023.562935.2983.","journal-title":"Iran J Pathol"},{"issue":"8","key":"2546_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/metabo11080513","volume":"11","author":"G Yang","year":"2021","unstructured":"Yang G, Fontaine D, Lodh S, Blumer J, Roopra A, Davis D. TCF19 impacts a network of inflammatory and DNA damage response genes in the pancreatic \u03b2-cell. Metabolites. 2021;11(8):513. https:\/\/doi.org\/10.3390\/metabo11080513.","journal-title":"Metabolites"},{"issue":"12","key":"2546_CR12","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/cbin.11189","volume":"43","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Chen G, Deng C, et al. TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1. Cell Biol Int. 2019;43(12):1416\u201324. https:\/\/doi.org\/10.1002\/cbin.11189.","journal-title":"Cell Biol Int"},{"issue":"2","key":"2546_CR13","first-page":"655","volume":"24","author":"W Du","year":"2020","unstructured":"Du W, Huang Z, Luo L, et al. TCF19 aggravates the malignant progression of colorectal cancer by negatively regulating WWC1. Eur Rev Med Pharmacol Sci. 2020;24(2):655\u201363.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"01","key":"2546_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4149\/neo_2018_171227N845","volume":"66","author":"CX Zeng","year":"2019","unstructured":"Zeng CX, Fu SB, Feng WS, Zhao JY, Li FX, Gao P. TCF19 enhances cell proliferation in hepatocellular carcinoma by activating the ATK\/FOXO1 signaling pathway. Neo. 2019;66(01):46\u201353. https:\/\/doi.org\/10.4149\/neo_2018_171227N845.","journal-title":"Neo"},{"issue":"6","key":"2546_CR15","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/diagnostics14060660","volume":"14","author":"I Ili\u0107","year":"2024","unstructured":"Ili\u0107 I, Cvetkovi\u0107 J, Ili\u0107 R, et al. Differences in histological subtypes of invasive lobular breast carcinoma according to immunohistochemical molecular classification. Diagnostics. 2024;14(6):660. https:\/\/doi.org\/10.3390\/diagnostics14060660.","journal-title":"Diagnostics"},{"key":"2546_CR16","doi-asserted-by":"publisher","first-page":"1357726","DOI":"10.3389\/fimmu.2024.1357726","volume":"15","author":"TE Velazquez-Caldelas","year":"2024","unstructured":"Velazquez-Caldelas TE, Zamora-Fuentes JM, Hernandez-Lemus E. Coordinated inflammation and immune response transcriptional regulation in breast cancer molecular subtypes. Front Immunol. 2024;15:1357726. https:\/\/doi.org\/10.3389\/fimmu.2024.1357726.","journal-title":"Front Immunol"},{"key":"2546_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216995","volume":"597","author":"S Li","year":"2024","unstructured":"Li S, Zhang N, Zhang H, et al. Deciphering the TCF19\/miR-199a-5p\/SP1\/LOXL2 pathway: implications for breast cancer metastasis and epithelial-mesenchymal transition. Cancer Lett. 2024;597: 216995. https:\/\/doi.org\/10.1016\/j.canlet.2024.216995.","journal-title":"Cancer Lett"},{"issue":"4","key":"2546_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian J, Rao AA, Nothaft FA, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314\u20136. https:\/\/doi.org\/10.1038\/nbt.3772.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"2546_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS J Integr Biol. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS J Integr Biol"},{"issue":"1","key":"2546_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinform. 2013;14(1):7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","journal-title":"BMC Bioinform"},{"issue":"2","key":"2546_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400-416.e11. https:\/\/doi.org\/10.1016\/j.cell.2018.02.052.","journal-title":"Cell"},{"issue":"4","key":"2546_CR22","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.003.","journal-title":"Immunity"},{"issue":"5","key":"2546_CR23","doi-asserted-by":"publisher","first-page":"E600","DOI":"10.1152\/ajpendo.00147.2013","volume":"305","author":"KA Krautkramer","year":"2013","unstructured":"Krautkramer KA, Linnemann AK, Fontaine DA, et al. Tcf19 is a novel islet factor necessary for proliferation and survival in the INS-1 \u03b2-cell line. Am J Physiol Endocrinol Metab. 2013;305(5):E600\u201310. https:\/\/doi.org\/10.1152\/ajpendo.00147.2013.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"2546_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12935-024-03254-z","volume":"24","author":"J Lim","year":"2024","unstructured":"Lim J, Hwang YS, Yoon HR, et al. PLK1 phosphorylates RhoGDI1 and promotes cancer cell migration and invasion. Cancer Cell Int. 2024;24(1):73. https:\/\/doi.org\/10.1186\/s12935-024-03254-z.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2546_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12967-024-04910-8","volume":"22","author":"M Chen","year":"2024","unstructured":"Chen M, Zhang S, Wang F, He J, Jiang W, Zhang L. DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target. J Transl Med. 2024;22(1):209. https:\/\/doi.org\/10.1186\/s12967-024-04910-8.","journal-title":"J Transl Med"},{"issue":"8","key":"2546_CR26","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.7150\/jca.93621","volume":"15","author":"Z Liu","year":"2024","unstructured":"Liu Z, Wang J, Xie S, et al. Lasiokaurin regulates PLK1 to induce breast cancer cell G2\/M phase block and apoptosis. J Cancer. 2024;15(8):2318\u201328. https:\/\/doi.org\/10.7150\/jca.93621.","journal-title":"J Cancer"},{"key":"2546_CR27","doi-asserted-by":"publisher","first-page":"1447807","DOI":"10.3389\/fonc.2024.1447807","volume":"14","author":"E Zanini","year":"2024","unstructured":"Zanini E, Forster-Gross N, Bachmann F, et al. Dual TTK\/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination. Front Oncol. 2024;14:1447807. https:\/\/doi.org\/10.3389\/fonc.2024.1447807.","journal-title":"Front Oncol"},{"issue":"19","key":"2546_CR28","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.3390\/cancers16193259","volume":"16","author":"S Sreekumar","year":"2024","unstructured":"Sreekumar S, Montaudon E, Klein D, et al. PLK1 inhibitor Onvansertib enhances the efficacy of alpelisib in PIK3CA-mutated HR-positive breast cancer resistant to palbociclib and endocrine therapy: preclinical insights. Cancers. 2024;16(19):3259. https:\/\/doi.org\/10.3390\/cancers16193259.","journal-title":"Cancers"},{"issue":"4","key":"2546_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1021\/acs.biochem.9b00771","volume":"59","author":"P Mondal","year":"2020","unstructured":"Mondal P, Sen S, Klein BJ, et al. TCF19 promotes cell proliferation through binding to the histone H3K4me3 mark. Biochemistry. 2020;59(4):389\u201399. https:\/\/doi.org\/10.1021\/acs.biochem.9b00771.","journal-title":"Biochemistry"},{"key":"2546_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101978","volume":"45","author":"Y Tian","year":"2024","unstructured":"Tian Y, Xin S, Wan Z, et al. TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf\/MEK\/ERK signaling pathway. Transl Oncol. 2024;45: 101978. https:\/\/doi.org\/10.1016\/j.tranon.2024.101978.","journal-title":"Transl Oncol"},{"issue":"4","key":"2546_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/jmedgenet-2020-107410","volume":"59","author":"P Ji","year":"2022","unstructured":"Ji P, Chang J, Wei X, et al. Genetic variants associated with expression of TCF19 contribute to the risk of head and neck cancer in Chinese population. J Med Genet. 2022;59(4):335\u201345. https:\/\/doi.org\/10.1136\/jmedgenet-2020-107410.","journal-title":"J Med Genet"},{"key":"2546_CR32","doi-asserted-by":"publisher","first-page":"1449441","DOI":"10.3389\/fimmu.2024.1449441","volume":"15","author":"J Xu","year":"2024","unstructured":"Xu J, Gao H, Azhar MS, et al. Interleukin signaling in the regulation of natural killer cells biology in breast cancer. Front Immunol. 2024;15:1449441. https:\/\/doi.org\/10.3389\/fimmu.2024.1449441.","journal-title":"Front Immunol"},{"key":"2546_CR33","doi-asserted-by":"publisher","first-page":"1227572","DOI":"10.3389\/fimmu.2023.1227572","volume":"14","author":"S Lutz","year":"2023","unstructured":"Lutz S, Klausz K, Albici AM, et al. Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells. Front Immunol. 2023;14:1227572. https:\/\/doi.org\/10.3389\/fimmu.2023.1227572.","journal-title":"Front Immunol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02546-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02546-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02546-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T14:54:37Z","timestamp":1749567277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02546-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2546"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02546-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of Anhui Provincial Hospital (No. 2022-ZNW-02), and all patients gave informed consent. This study was reviewed and approved by the University of Science and Technology of China Animal Experimentation Ethics Committee (No. USTCACUC192401041). All procedures of animal study were performed according to the protocols approved by the Institutional Animal Ethics Care and Use Committee of the University of Science and Technology of China. According to the Ethics Committee, the maximum tumor size must not exceed 20\u00a0mm in any direction in an adult mouse, and in our experiment, the maximal tumor size remained within this limit.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1047"}}